BioGaia AB provided preliminary earnings guidance for the third quarter of 2021 and sales guidance for the full year 2021. Sales for the third quarter are preliminarily estimated at SEK 174 million. Operating profit for the third quarter is preliminarily estimated at SEK 67 million. Full-year sales are largely expected to be in line with expectations.